| | | |

Mesothelioma Survivors May Not Have Enough Knowledge of Nutrition

New evidence suggests that too many long-term survivors of malignant mesothelioma and other cancers may not be following the dietary guidelines that could keep them healthy for a lifetime.

Researchers from Johns Hopkins and Drexel University recently analyzed the diets of 53 adult cancer survivors and found that many are not adequately prepared to follow a cancer-preventing diet indefinitely.

Mesothelioma Survival and DIet

Multiple studies point to the value of a diet high in antioxidant-rich fruits and vegetables as a way to prevent cancer or to support the body during aggressive treatment for a cancer such as malignant mesothelioma.  

The lifestyles of long-term survivors like Paul Kraus, the Australian man who recently celebrated 20 years of survival from peritoneal mesothelioma, offer more evidence for a healthful diet as a way to remain vibrant and cancer-free.

Kraus, who wrote the best-selling mesothelioma book “Surviving Mesothelioma and Other Cancers”,  not only consumes mounds of produce and supplements each day, but also exercises and meditates regularly.

Cancer Survivors Unprepared for Better Diets

But new research suggests that other mesothelioma patients and survivors may not be following Kraus’ example. The new study published in the journal Integrative Cancer Therapies asked survivors of three cancers (breast, prostate, and non-Hodgkin’s lymphoma) to track their diets over three 24-hour periods.

“Results were used to classify respondents on 2 metrics of healthful eating,” explains study author Ann Carroll Klassen, PhD, of the Dornsife School of Public Health at Drexel University in Philadelphia.

The two metrics were the Healthy Eating Index 2010, a measure of dietary quality developed by the US government, and a 9-item index based on current dietary recommendations.

Each cancer survivor’s diet journal was then used to initiate a discussion of their dietary behaviors, healthy eating, and the importance of diet in cancer prevention and survivorship. The researchers were not encouraged by what they learned.

“Most survivors had received little nutrition counseling as part of their cancer care, highlighting the importance of holistic, household-oriented nutrition education for maintaining health among long-term cancer survivors,” concludes Dr. Klassen.

Who Are the Healthiest Cancer Survivors?

According the the researchers, the cancer survivors following the most healthful diets tended to be women of normal weight who had never smoked and had more socioeconomic resources.

Cancer survivors who lived in homes where other family members were also involved in the dietary decision-making tended to eat better than those who were on their own. Mesothelioma patient Paul Kraus’ own story bears that out; he and his wife learned about and made significant dietary changes together.

Malignant mesothelioma is an especially aggressive cancer that affects as many as 2,500 new patients in the US annually. Most of these patients are people who had been exposed to asbestos either in their workplace or their environment.

Source:

Klassen, AC, et al, “We’re Just Not Prepared for Eating Over Our Whole Life”: A Mixed Methods Approach to Understanding Dietary Behaviors Among Longer Term Cancer Survivors, Journal of Integrative Therapies, October 3, 2017

Similar Posts

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • |

    Chemical in Wine May Improve Mesothelioma Treatment

    There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…

  • | |

    Micro-RNAs May Offer New Way to Fight Mesothelioma

    Scientists at one of the world’s top mesothelioma research centers, the Asbestos Diseases Research institute in Sydney, Australia, say that restoring the expression of certain micro RNAs in the cells of mesothelioma patients may offer a new way to fight the disease. A microRNA is a small RNA molecule which is involved in the regulation of gene expression. According to a new report in the Annals of Oncology, the Australian scientists found reduced expression of the micro RNA-15 family (miR-15/16) in the cells of mice with mesothelioma. “When malignant pleural mesothelioma cell lines were compared with the normal mesothelial cell line MeT-5A, the downregulation of miR-15/16 was 2- to 10-fold,” they report. This finding is consistent with previous cancer research…

  • | |

    Treatment Uses Herpes Virus to Shrink Mesothelioma Tumors

    Researchers at a hospital in Sheffield, England are testing a potential new mesothelioma treatment based on the same virus that causes herpes. The small-scale trial is the first in the world to test the modified herpes simplex virus, HSV1716, in human mesothelioma patients. HSV1716 has been genetically engineered to infect and kill cancer cells without harming healthy cells. In laboratory studies on mesothelioma and some other cancers, it has been shown to be effective at shrinking tumors while causing limited toxicity. Just as significantly, HSV1716 increased survival rates among mice with various human cancers. The Phase I/II trial at Sheffield Experimental Cancer Medicine Centre is the next stage in development of HSV1716 as a viable mesothelioma treatment. The goal of…

  • | |

    New Mesothelioma Drug Kills Cancer Stem Cells

    Citing “significant enthusiasm within the mesothelioma community”, the manufacturers of a promising new mesothelioma drug say they have begun a major test of the drug in patients. Massachusetts-based Verastem, Inc. focuses on drugs that fight cancer by attacking the stem cells that give rise to them. Earlier this summer, the FDA granted orphan drug status to their stem cell inhibitor, defactinib, for the treatment of mesothelioma. The designation, which is reserved for drugs that fight the rarest of diseases, helps pave the way for testing and faster approval, depending on the results of clinical trials. “Development of a drug that preferentially kills cancer stem cells is a promising approach, as many standard-of-care treatments have been shown to either have no…

  • | |

    Mesothelioma Study Finds New Treatment Target

    Immunotherapy, which involves reprogramming T-cells to find and attack cancer cells, is one of the fastest-growing areas of cancer research. One of the biggest challenges of immunotherapy is how to harness the power of T-cells against cancer without also turning them against healthy cells. A new study conducted in Switzerland and published in the Journal of Translational Medicine addressed the problem by reprogramming T-cells to recognize and attack mesothelioma cells that express a specific protein. Fibroblast Activation Protein (FAP) is expressed on the surface of tumor-associated fibroblast cells which are found in the connective tissue of mesothelioma tumors. FAP is also found in mesothelioma cells and may play a role in the start of cancer, as well as the growth…